BMO Capital Maintains Market Perform on Zimmer Biomet Holdings, Lowers Price Target to $101

Benzinga · 3d ago
BMO Capital analyst Vik Chopra maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Market Perform and lowers the price target from $102 to $101.